- Home
- JTAI vs PHIO Comparison
JTAI vs PHIO Comparison
Compare JTAI & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- PHIO
- Stock Information
- Founded
- JTAI 2018
- PHIO 2011
- Country
- JTAI United States
- PHIO United States
- Employees
- JTAI N/A
- PHIO N/A
- Industry
- JTAI Blank Checks
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- PHIO Health Care
- Exchange
- JTAI Nasdaq
- PHIO Nasdaq
- Market Cap
- JTAI 2.7M
- PHIO 2.3M
- IPO Year
- JTAI N/A
- PHIO N/A
- Fundamental
- Price
- JTAI $5.35
- PHIO $2.21
- Analyst Decision
- JTAI
- PHIO Strong Buy
- Analyst Count
- JTAI 0
- PHIO 1
- Target Price
- JTAI N/A
- PHIO $36.00
- AVG Volume (30 Days)
- JTAI 246.5K
- PHIO 41.4K
- Earning Date
- JTAI 11-14-2024
- PHIO 11-14-2024
- Dividend Yield
- JTAI N/A
- PHIO N/A
- EPS Growth
- JTAI N/A
- PHIO N/A
- EPS
- JTAI N/A
- PHIO N/A
- Revenue
- JTAI $15,028,926.00
- PHIO N/A
- Revenue This Year
- JTAI $42.02
- PHIO N/A
- Revenue Next Year
- JTAI N/A
- PHIO N/A
- P/E Ratio
- JTAI N/A
- PHIO N/A
- Revenue Growth
- JTAI 46.66
- PHIO N/A
- 52 Week Low
- JTAI $5.17
- PHIO $2.17
- 52 Week High
- JTAI $1,005.75
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- JTAI 26.28
- PHIO 32.01
- Support Level
- JTAI $5.90
- PHIO $2.49
- Resistance Level
- JTAI $10.36
- PHIO $3.70
- Average True Range (ATR)
- JTAI 2.17
- PHIO 0.31
- MACD
- JTAI -0.52
- PHIO -0.10
- Stochastic Oscillator
- JTAI 1.58
- PHIO 2.75
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.